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Abstract  
It is widely agreed that social factors are related to health outcomes: much research served 
to establish correlations between classes of social factors on the one hand and classes of 
disease on the other hand. However, why and how social factors are an active part in the 
aetiology of disease development is something that is gaining attention only recently in the 
health sciences and in the medical humanities. In this paper, we advance the view that, just 
as bio-markers help trace the causal continuum from exposure to disease development at 
the biological level, socio-markers ought to be introduced and studied in order to trace the 
social continuum from exposure to disease development. We explain how socio-markers 
differ from social indicators and how they can be used in combination with bio-markers in 
order to reconstruct the mixed mechanisms of health and disease, namely mechanisms in 
which both biological and social factors have an active causal role. 
1. Introduction  
In the health sciences, the relationship between socio-economic factors and health has been 
long studied, especially by epidemiologists and sociologists. That certain diseases and health 
conditions are strongly associated with certain socio-economic factors is well established 
and documented. In particular, considerable attention has been paid to how inequalities at 
the socio-economic level are mirrored by inequalities at health level, and vice-versa (House, 
2002; Marmot, 2005; McLean et al., 2014). In recent years, the relationship between the 
biological and the social dimensions of health has been addressed from novel perspectives 
(Vineis, Avendano-Pabon, et al., 2017). In the field of the health sciences, ground-breaking 
studies such as the EU-funded project Lifepath (https://www.lifepathproject.eu/) and the 
research conducted at the Center For Youth Wellness in San Francisco 
(https://centerforyouthwellness.org/) have cast a new light on the social aspects involved in 
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the aetiology of disease (Bucci, Marques, Oh, & Harris, 2016; Purewal, Marques, Koita, & 
Bucci, 2016; Vineis, Illari, & Russo, 2017; Walker & Carrion, 2015). In addition, new 
discussions in the health sciences have emerged in relation to the complex processes of 
disease formation and prevention (Castagné et al., 2016; Davillas, Benzeval, & Kumari, 2017; 
Galea, 2007; Kelly-Irving & Delpierre, 2017; Vineis, Chatziioannou, et al., 2017). In the 
medical humanities, instead, novel theoretical studies have offered insights into the 
interaction of the social and the biological dimensions of health and its consequences for 
health policies (Berkman, Glass, Brissette, & Seeman, 2000; Kelly, Kelly, & Russo, 2014; Kelly 
& Russo, 2017). We take a broad perspective on what counts as ‘medical humanities’, 
encompassing approaches coming from the social studies, history and philosophy (of 
science and, specifically, of medicine), and ethics (Arnott et al., 2001).   
In the health sciences, the Lifepath project is particularly worthy of attention since it is the 
third of a series of projects that have studied the causal relationships between health and 
environmental exposure through biomarkers. Together with Envirogenomarkers 
(www.envirogenomarkers.net/) and EXPOsOMICS (https://www.exposomicsproject.eu/), 
Lifepath contributes to understanding exposure and disease development using innovative 
methodologies and concepts (Kelly-Irving & Delpierre, 2017; Vineis, Chadeau-Hyam, et al., 
2017; Vineis & Chadeau-Hyam, 2011; Vineis & Perera, 2007). This line of research, given its 
ground-breaking character, also attracted the attention both of the medical humanities 
(Russo and Williamson 2012; Vineis, Illari, and Russo 2017), and of philosophy of science, 
(Canali 2016; Illari and Russo 2016).   
In particular, Lifepath brings to the fore new philosophical and methodological questions 
related to the biological and the social dimensions of health. In fact, current research 
projects using biomarkers typically try to elucidate how socio-economic factors affect 
disease development at the biological level. Recently, however, the literature in medical 
methodology – a strand of research in the medical humanities that rigorously investigates 
study design, research techniques, as well as foundational issues in medical research– has 
been pressing on other specific conceptual issues still posing a threat to the advancement of 
the mechanistic understanding of this phenomenon. More specifically, the details of a mixed 
mechanism in which both socio-economic and biological factors play a causal role needs 
further specification, both conceptually and methodologically. 
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In this paper, we focus on one specific conceptual issue, namely how socio-economic factors 
can be more than just ‘indicators’ for broader social or health conditions. We ask the 
question whether, in analogy to bio-markers, which help trace the trajectory from exposure 
to disease at the biological level, we can identify and study socio-markers that would work 
in a similar way, namely helping to trace the trajectory from exposure to disease 
development. 
The paper is organised as follows. In section 2 and 3 we introduce the study of social 
determinants of health and disease, paying particular attention to how social factors are 
measured. We claim that, over the last few years, the biological component of the mixed 
mechanisms of health has been explored at a fine-grained level, whereas the social 
component is analysed at a rather coarse-grained level through socio-economic indicators 
and proxies. In section 4, we introduce the idea of causation as information transmission, 
which constitutes a theoretical basis for using biomarkers in the study of disease 
mechanisms at the molecular level. Then, by analogy with biomarkers, we introduce 
sociomarkers as a tool to reconstruct the trajectory from exposure to disease; this, we think, 
explicates the causal role of social factors in disease mechanisms. Section 5 further develops 
on two aspects: the mixed nature of disease mechanism and the need to study these 
mechanisms at the population and at the individual level. These two characteristics of 
disease causation lend further support to the need to introduce sociomarkers, next to 
biomarkers. Finally, in the conclusion we claim that sociomarkers can help to address three 
challenges characterising the study of mixed mechanisms of disease: (i) the discrepancy 
between the mechanistic understanding at the biological level and at the social level; (ii) the 
discrepancy between the study at the individual level of the biological components of health 
and the study at the population level of the social components of health; (iii) the need for all 
these dimensions (individual/population and social/biological) for the purposes of policy 
interventions. 
2. Social determinants of health 
It is widely agreed that certain diseases arise from a set of risks identified at the behavioural 
and social level, such as people’s smoking, dietary habits and social norms (Commission on 
the Social Determinants of Health, 2008; Davillas & Pudney, 2017; Hernández-Quevedo, 
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Masseria, Mossialos, European Commission, & Eurostat, 2010). It is also generally accepted 
that the health of populations is shaped by certain ‘social determinants’ like social ties, 
poverty, and low education (Braveman & Gottlieb, 2014; Wilkinson & Marmot, 2003). 
Despite this broad core of agreement, however, social and behavioural factors are seldom 
brought into the aetiological discussion of mechanisms of health and disease. This is partly 
because social factors are thought to provide a classification of the parts of the population 
more at risk. Their relevance is associated with categorization, not explanation. 
Furthermore, even when it is accepted that social factors play an active role in the 
development of disease, how to integrate socio-behavioural and biological variables in order 
to develop all-encompassing models of disease causation remains largely underdeveloped. 
Still now, biological and social factors are considered distinct factors, whose causal role is 
different and whose action is far from being integrated. This assumption is evident in the 
linguistic use of terms such as ‘proximal’ and ‘distal’ causes, where biological factors are 
proximal and thus directly affecting health and disease, whereas social factors are distal, just 
wider determinants of health, but not proper causes (Kelly et al., 2014, p. 309; Krieger, 
2008). 
And yet, the need of integrated models of disease causation, where biological and social 
factors are considered equally relevant to the causal understanding of health has been 
claimed in both camps of the health sciences (Velupillai et al., 2008; Vineis & Kriebel, 2006) 
and the medical humanities (Kelly et al., 2014; Russo, 2009).  
This offered a raison d’être for those epidemiological studies putting at the heart of their 
investigations how social factors might influence health (Galea & Link, 2013). To give an 
example, Castagné et al. (2016) measured inflammation through 28 markers and related 
them to a number of indicators for the socio-economic position of individuals.  Attempts to 
enhance our understanding of the social component of health, however, have been often 
downgraded by the increasing gap between the biological and the social research 
advancements. Indeed, while from the biological point of view the striking technological 
improvements have contributed to enhancing the mechanistic understanding of disease at 
the biological level (Kronfeldner, 2014), at the social level the progress has not been as fast.      
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This brings us to the present, when the biological component of the mechanisms of health is 
explored at a fine-grained level, but the social component is still analysed at a rather coarse-
grained level. Indeed, social factors at the population level are often explored by using only 
the traditional socio-economic position indicators. 
Traditionally, socio-economic status has been measured by using three social indicators: 
income, occupation, and educational level. Studies based on such indicators have provided 
useful information, and yet they suffer from substantial limitations. The main problem 
concerns the kind of knowledge that can be derived from this approach: the analysis of the 
socio-economic indicators highlights that socio-economic factors are relevant to health, 
however it does not establish why this is the case, namely how social factors affect health. 
In other words, while these measurements can show that there are robust correlations 
between specific socio-economic conditions and health, they are not sufficient to uncover 
the mechanisms through which such socio-economic conditions affect health (Muntaner, 
2013). 
The rationale behind this paper is that even the more accurate description of the biological 
aspect of disease causation is not sufficient to fully understand the phenomena of health 
and disease and to address questions concerning prevention and interventions. We follow 
existing discussions in understanding some mechanisms of health as ‘mixed mechanisms’, in 
which both biological and social factors have an active causal role (Kelly et al., 2014; Russo, 
2009). We do not look at those mechanisms operating only at the biological level (such as 
the development of disease due to random genetic mutations) or merely at the social level 
(such as the way in which, through the lack of access to healthcare, socio-economic position 
can cause mortality). In this paper, and in analogy with biomarkers, we contribute to the 
characterisation of mixed mechanisms by sketching a new way to approach the social 
component of health through the identification of sociomarkers at the individual level. 
In the literature, the definition of biomarkers is not unanimous (see for instance the 
International Programme on Chemical Safety (2001) and the Biomarkers Definitions 
Working Group (2001)). The main aspect of biomarkers is, according to us, that they are 
measures of something: they are always used as biological clues or measures to reconstruct 
the continuum from exposure to disease. In parallel, we take sociomarkers to be the 
corresponding social measures at the individual level that allow us to understand how socio-
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economic factors ‘get under the skin’ and affect the biological level – we return to this point 
later in section 4.2. Our approach tackles a fundamental issue associated with the study of 
the social realm that is not yet entirely resolved: the problem of measuring the social. 
3. Measuring the social 
The study of the social dimensions of health requires the use of some measures at the social 
level. How to measure social phenomena, however, is a matter of debate, especially 
considering that not all concepts that can be measured at the social level are alike.  
Some concepts refer to certain qualitative or quantitative characteristics that things have, 
such as the average age at marriage in a specific country or the average female pay rate. 
Other concepts categorize things according to several loosely interconnected features, as in 
the case of ‘poverty’ or ‘socio-economic position’. 
When concepts cover specific features, the selection of the methods used to generate 
accurate and precise measures is more straightforward and the measures are generally 
direct. There is no need to develop indirect measurement procedures: in order to know how 
many women live in a neighbourhood, for example, researchers can directly count them.  
On the contrary, when a concept is multifaced or constructed in various ways, the choice of 
the measurement procedures is controversial and is likely to entail the sacrifice of some of 
its aspects. Socio-economic position, for instance, can refer both to material and social 
resources and assets, and to individuals’ rank or status in a social hierarchy (Krieger, 2001). 
The measurement procedure is in general indirect and requires the selection of indicators or 
indices. In this case, researchers have two options: they can either develop/choose various 
indicators to measure all the dimensions characterizing such a concept, or they can select 
more precisely only some of the features constituting the concept and measure them, 
accepting to leave behind the other dimensions characterizing the concept. Measurements 
of concepts such as socio-economic position or poverty are likely to differ greatly, 
depending on how they are conceptualised. 
Note that this distinction between simple and multifaced concepts does not correspond to 
the distinction between observable and unobservable things. Although certain simple 
concepts can be directly observed (like a person’s sex), there are cases where observation 
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cannot be performed with precision (like in the case of age). In the case of young individuals 
applying for the international protection without proper birth documentations, for instance, 
physicians use measurements obtained through wrist radiographs and clavicle computerized 
tomography to estimate age (Sauer, Nicholson, & Neubauer, 2016). 
The fact that some concepts are not easily observable has a great impact on the social 
sciences, as measuring them appears challenging. Researchers tackle this problem with 
proxies. Unlike indicators, proxies are not supposed to represent concepts. A proxy is a 
measure that correlates to the unobservable or unmeasurable concept under study 
sufficiently highly to be used as its predictor (Sapsford, 2006, p. 145).  
Some examples may clarify this point: let us consider the way in which the socio-economic 
status is studied in epidemiological studies. In low- and middle-income countries, given the 
shortcomings of available measures, the presence or absence of night-time lights visible 
from space is increasingly used as a proxy for the concept of socio-economic position (Chen 
& Nordhaus, 2011). Amongst academic research and within Government policy in England 
and Wales, instead, the Free School Meal Eligibility is very often used as a proxy for socio-
economic position (Hobbs, Vignoles, & Centre for the Economics of Education (Great 
Britain), 2007). Recently, in addition, scholars in the UK have also proposed the use of the 
council tax band as an alternative proxy (Howe et al., 2012). The number attached to the 
presence of night-time lights in a specific zone, the Free School Meal Eligibility and the 
council tax band are not supposed to structurally correspond to the concept of socio-
economic position. Rather, given the absence of available measures representing it, 
researchers use alternative data to obtain information about that concept.   
The adequacy of measures and proxies entails, hence, different questions. As for direct and 
indirect measures based on indicators, researchers have to establish whether the measures 
correctly represent the phenomena. In other words, they have to examine the adequacy of 
the relation between the concept and the numerical measurement. In the case of a proxy, 
adequacy requires the correlation between the proxy and the phenomenon to be 
sufficiently high. These distinctions are illustrated in Table 1.  
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Table 1: This table recaps the terms used in the literature, where they apply and 
their purpose. 
Such an approach to measuring the social has allowed for the accumulation of a large and 
compelling body of evidence demonstrating that socio-economic factors are correlated to a 
wide range of health outcomes. The result of a meta-analysis conducted by Galea and 
colleagues (2011), for instance, showed that the number of U.S. deaths in 2000 correlated 
to socio-economic factors such as low education, racial segregation, and low social support, 
and that such a correlation was comparable to the number of death correlated to 
cerebrovascular disease and lung cancer. Although this growing weight of evidence reflects 
strong associations between socio-economic factors and health, the study of socio-
economic indicators and proxies does not help to uncover the causal mechanisms behind 
them. It follows that socio-economic factors are rarely brought into the aetiological 
discussion of mechanisms of health. 
At the biological level, instead, much attention has been paid to eliciting the mechanisms 
behind correlations at the individual level, trying to understand them at an increasing level 
of detail. Researchers pinned down the biological and chemical basis of disease causation 
until the molecular level, and in these studies biomarkers play an essential role. Some 
interesting findings have been established in recent years through the study of biomarkers, 
yet without a mechanistic understanding of the social component of health, social 
epidemiology runs the risk of veering towards biologic reductionism (Muntaner, 2013).  
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4. Markers 
4.1 Markers and information transmission 
In general, causal claims in social epidemiology involve statements about risks: scientists 
want to know whether certain socio-economic conditions are good predictors of disease. As 
considered above, however, researchers do not only aim at claiming that socio-economic 
factors are correlated to health, they want to establish (i) that such factors are causally 
linked to health outcomes and (ii) how they can cause health outcomes. While the 
recognition that there is a causal link can be obtained through different methods, typically, 
the ‘how’ question is answered by considering the causal process linking the putative causal 
factor to the effect at the biological level.  
In similar cases, the continuum is explored by collecting information through markers. In the 
context of the biomedical sciences, they are most often referred to as biomarkers. Such 
markers are clues, signals to detect in order to understand how factors at different 
molecular levels can be causally linked to different stages of disease development. It is 
important to note that markers are not just ‘objects out there’. Sometimes, they are 
described in terms of ‘events’ in the continuum from the cause to the effect (Schulte & 
Perera, 1993), other times they are considered ‘possible intersecting signals’ representing 
parts of an active process (Chadeau-Hyam et al., 2011). The key feature of markers is that 
they are always marks of specific links, events, or processes. It is impossible to establish 
what objects count as markers in the abstract: markers are not defined in terms of intrinsic 
properties or correlations, but in terms of the function they have within particular biological 
processes under investigation. It follows that researchers have to decide whether something 
is a marker or not by considering the concrete research situations in which markers are 
studied, rather than on a priori set of identification criteria. 
While the idea of a marker – and especially a biomarker – is most common in contemporary 
biomedical research, it is worth noting that it had already been introduced in the philosophy 
of causality since the 1980s. Causal processes can be characterized in several different ways. 
One of the prominent interpretations is Wesley Salmon’s ‘mark transmission theory’ (Dowe, 
1992; Salmon, 1984). According to this account, what makes causal processes different from 
non-causal or pseudo-processes is the fact that causal processes are the ones transmitting 
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marks. For instance, a moving car can be considered a causal process because, if we mark or 
dent it, such a mark will be carried along with the car, and it will remain detectable at later 
stages. On the contrary, if we try to mark the car’s shadow (for instance interrupting the 
shadow by shining a light), that kind of mark will not travel with the car at later stages, 
therefore the mark will not be transmitted. Unlike the car’s example, however, there are 
many situations in which a process cannot be marked: this is the reason why Salmon 
formulated his proposal in counterfactual terms: a process is causal if and only if, if it were 
marked, the mark would be transmitted to later stages of the same process.  
Salmon’s approach is intuitively strong but limited: it is specifically tailored to physics, and 
considers marks as physics quantities such as energy and momentum. Consequently, it 
cannot be directly used as a conceptual tool to understand causal links that cannot be 
spelled out with the language and tools of physics. This limitation has long been recognized 
in the health sciences, where researchers explicitly recognize the importance of studying the 
reality at different levels (such as the biological and the social levels), for instance using a 
longitudinal approach, where marks are observed rather than introduced (Vineis, 1997). 
However, an adjustment can be made to tackle this problem: a marker might be something 
that is already transmitted by a causal process, rather than a ‘physics’ mark that should be 
introduced. This would appear in line with what is done in epidemiological studies (such as 
in the aforementioned Lifepath, EXPOsOMICS, or Envirogenomarkers), where researchers 
follow a longitudinal thread of marks (observing, for instance, that aflatoxin causes the 
formation of adducts, that in turn induce p53 mutations that are the same found in liver 
cancer). In the philosophy of causation and philosophy of medicine literature, it has been 
recently suggested that the link shown by markers is better conceptualized using the notion 
of “information transmission” (Illari & Russo, 2016; Vineis, Illari, et al., 2017). 
Thus, markers can be conceptualized as signals of transmission of information. It is 
important to note that the notion of information transmission is located at the level of 
epistemology, not of ontology: information transmission deals with the way in which 
scientists reconstruct the continuum between factors at different levels (Vineis, Illari, & 
Russo, 2017). This proposal is not necessarily in contrast with the prominent mechanistic 
thinking now widespread in philosophy of causality and in the sciences: when looking for 
markers, indeed, researchers might be guided by mechanistic knowledge. Illari and Russo 
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(2016) described mechanisms as information channels where information flows and 
markers (i.e. the intersecting signals) can be found. 
The generality of the information-transmission idea, and of how markers help (re)trace the 
link from putative causes to putative effects, allows for the development of a general 
epistemological framework for thinking about causality across different levels (individual, 
population) and across different types of factors (biological, social). For this reason, 
understanding causality as information transmission enables us to provide a mechanistic 
explanation of disease that includes both biological and social factors.   
It remains to explain, however, how, more specifically, markers can help detect links at the 
biological level, and even at the social level. This is what the following two sections aim to 
do. At the biological level, the development of new technologies, as well as the availability 
of large datasets, led to an increasing use of biological markers. In parallel, we argue it is 
high time to approach social measures not as ‘indicators’ and ‘proxies’, but as sociomarkers.  
4.2 Biomarkers 
The striking technological advancements of the last few decades have contributed to 
enhancing the mechanistic understanding of disease from a biological point of view. The 
main protagonists of this advancement are the so-called ‘-omics’ technologies and their 
products, known by the name of biological markers, or biomarkers. One of the major 
contributions of ‘-omics’ technologies is through the identification of relevant markers at 
the molecular level. Traditionally, epidemiology established correlations between macro-
variables: those associated with the environment and those describing diseases. 
Biomarkers, instead, allow researchers to go much smaller: both the macro-level factors 
themselves, such as air pollution, and their effects can now be measured at the molecular 
level. 
Biomarkers do not necessarily correspond to specific molecular entities. Often, they are 
constructed by cross-checking large datasets and using background information about the 
processes that biomarkers are supposed to signal. They are not studied per se, or to identify 
those entities causing health effects, but to understand the trajectory of disease 
development. They can be conceptualized as the ‘missing links’ between factors at the 
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population (macro) level (such as external or environmental exposure) and factors at the 
individual (micro) level (such as DNA alterations leading to disease). By helping to detect 
some key stages linking such factors, biomarkers suggest the existence of a continuum 
between them. 
Biomarkers can mark salient points in the continuum from exposure to disease in several 
ways, consequently they can stand in different relationships with each other, the effect and 
the cause. Diagrams consisting in variables linked by arrows or lines, also known by the 
name of Directed Acyclic Graphs (DAGs), can be used to illustrate relationships that are 
relatively complicated and larger causal system based on inter-relationships relevant to 
health (Joffe, Gambhir, Chadeau-Hyam, & Vineis, 2012). In Figure 1, we illustrate most 
possible linkages between the biomarker and the phenomenon under study through the use 
of DAGs, where arrows represent causal relationships and lines simple correlations. 
 
Figure 1: (a) represents the situation in which the biomarkers B is part of the 
causal process linking the cause X and the effect Y. In (b), the biomarker B and 
the effect Y are correlated because both are caused by X. In (c), the biomarker B 
is correlated to the event Z, that is part of the process but cannot be measured. 
In (d), B is just correlated and is not causally linked to the effect Y. B may be, for 
instance, a background condition. 
Biomarkers are conceived and used to mark processes that happen at the biological level, 
reconstructing the link between exposure and disease. They shed light on several aspects of 
disease mechanisms at the molecular level, and contribute to early diagnosis and better 
prediction. However, disciplines such as social epidemiology or medical sociology have long 
established and pleaded for the important role of social factors for health (Braveman & 
Gottlieb, 2014). What remains to understand, is whether there is any way to shed light on 
the social mechanisms of health at the individual level. This is what we explore next. 
4.3 Sociomarkers 
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Rather than being considered competing approaches, the individual and population level 
can be reconciled through the study of sociomarkers: it is the analysis of sociomarkers at the 
individual level that can enhance our understanding of the social components of health at 
the population level.     
Traditionally, social epidemiology establishes correlations between health outcomes and 
population-level factors such as poverty and socio-economic position. On the contrary, 
sociomarkers can be used to trace social processes at the individual level, helping to find the 
missing link between social factors at the population level and health factors at the 
individual level.  
It is important to note that the shift from the notion of social indicators to the concept of 
sociomarkers does not necessarily require the collection of new measures. Available 
measures, already used as proxies and indicators, might count as markers. It is not the 
particular nature of measures, but how they are used that determines whether something is 
a sociomarker. The aim, when using sociomarkers, is to pick up signals to reconstruct the 
continuum from social factors to disease, in analogy with how biomarkers help pick up 
signals from exposure to disease at the biological level. In practice, this might require using 
socio-economic variables measured at the individual level, rather than aggregate level. This 
does not exclude the use of aggregate variables or of multi-level methods that use both 
population- and individual-level variables. In some cases, for instance, it could be possible to 
use population-level sociomarkers that describe the role of structural causes (this would go 
into the same direction as Galea and Link’s, according to which epidemiology is ‘all social’ 
(Galea & Link, 2013, p. 844)). It does suggest, however, how else individual-level variables 
that measure socio-demo-economic characteristics can be used. Individual-level variables, 
furthermore, might measure both individual behaviours (such as social interaction) and 
individual-level effects that depend on structural causes active at the population or macro 
level (such as violent behaviours caused by some structural features of society).  
When measures are used as sociomarkers, they are not associated with specific concepts, 
and are not supposed to have a structural correspondence with them, like indicators. 
Sociomarkers are always located in relation to the causal continuum. As biomarkers, they 
might be part of the continuum, or might be simply correlated to the continuum, as shown 
in Figure 1(b) and (c). When sociomarkers exhibit just a difference-making relationship with 
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the continuum, however, they do not act just as proxies. In causal reasoning proxies are 
used to establish that something (notably, what they stand for) makes a difference (for 
instance, using the council tax band as a proxy of poverty, we can claim that poverty  exerts 
an effect on health), while sociomarkers help to find out how something causes the effect 
(for instance, individual values of council tax bands should be linked to specific individual 
biological outputs). The ‘how’, again in analogy with biomarkers, is provided by the process 
linking socio-economic characteristics and health outcomes, and sociomarkers help 
intercept this process at relevant places, just as biomarkers do. In this way sociomarkers do 
more than just identifying social risks – they indicate where to intervene in the whole 
process. 
Recently, scholars have begun to use the label ‘markers’ for socio-economic measures in a 
rudimentary way. For instance, measures such as birthweight, household income, 
education, maternal smoking during pregnancy, mother's body mass index and mother's age 
at birth, known to affect later health, were used to explore how the link between socio-
economic position and health is mediated by certain social pathways (Barboza Solís et al., 
2016; Davillas et al., 2017). It is exactly when such measures are used, we claim, that a 
precise conceptualization of sociomarkers is needed.  
Let us consider an example: it is known that a low socio-economic status in early life is 
correlated with poor health and increased mortality in adulthood (Anda et al., 2006). At the 
social level, a general hypothesis is that socio-economic factors in childhood get under the 
skin (at the molecular level) through severe chronic stressors to which children are exposed 
(Miller, Chen, & Parker, 2011).  
To detect signals of this process at the social level, some researchers have used the so-called 
Adverse Childhood Experiences (ACEs). This expression describes certain stressful or 
traumatic events that can be experienced by children whilst growing up. The original ACEs 
study was conducted by the Centers for Disease Control and Prevention (CDC) in 
collaboration with the American integrated managed care consortium Kaiser Permanente 
(Felitti et al., 1998). In this study, researchers developed a list of 10 indicators of child 
adverse experiences: emotional abuse, physical abuse, emotional neglect,  physical neglect, 
contact sexual abuse, mother treated violently, alchoolic or drug users among the 
household members, not being raised by both biological parents, household member who 
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was imprisoned, household member who was chronically depressed, suicidal, mentally ill or 
in a psychiatric hospital.  
The original ACEs, as well as the new ACEs added in the literature such as separation from 
family and serious childhood illness (Hughes et al., 2017), have all the characteristics 
required to be used as sociomarkers. First, it is possible to use ACEs information as 
intersecting signals of a continuum. ACEs can indeed be employed to identify some key 
stages connecting social factors at the population level, such as the socio-economic position, 
and biological factors at the individual level (biomarkers). In such a way, ACEs are not just 
indicators, but sociomarkers that can help to establish how socio-economic determinants 
exert an impact on health through biological mechanisms. This is possible for two reasons. 
One the one hand, at the population level, ACEs appear to be more prevalent among 
children in low-income families: in the U.S., for instance, data from the National Survey of 
Children's Health (NSCH) showed that children in low- and middle-income families are more 
than twice as likely to experience two or more ACEs (Halfon, Larson, Son, Lu, & Bethell, 
2017). This prevalence, hence, supports the idea that socio-economic conditions during 
childhood could affect health through these adverse experiences. On the other hand, 
several studies have provided evidence of the associations between ACEs and allostatic load 
biomarkers, inflammatory biomarkers and cancer biomarkers (Barboza Solís et al., 2015; 
Kelly-Irving et al., 2013; Tietjen, Khubchandani, Herial, & Shah, 2012). Such correlations 
support the idea that ACEs could be the link connecting ‘the social’ and ‘the biological’, as 
described by Danese and McEwen (2012):  
“adverse childhood experiences are likely to signal high levels of environmental 
threat and to trigger adaptive responses in the nervous, endocrine, and immune 
systems in children” (Danese & McEwen, 2012, p. 31)  
Second, in contrast to traditional socio-economic indicators, ACEs help to investigate the 
processes from social events to biological changes at the individual level. Like biomarkers, 
ACEs are identified by examining real individuals: ACEs can be experienced only by real, 
individual children. This is particularly relevant if we consider that for each individual 
adverse childhood experiences can vary in duration, timing, and type, and that individual 
characteristics can lead to very different responses to very similar adversities. In this and 
similar cases, hence, sociomarkers would help us to capture some aspects of the 
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subjective/reflexive/perceived dimension of the social: the assumption justifying the use of 
ACEs would be that events such as the incarceration of a parent can be associated with an 
individual, perceived dimension, that can in turn influence the individual’s health. 
5. Types of markers and levels of causation 
In section 4.2 we suggested that, next to biomarkers, we need to study sociomarkers too. 
Bio- and socio-markers help with identifying/detecting the process from exposure 
(biological and social) to health outcomes at two levels: (i) the biological and social level, 
and (ii) the individual and population level. Concerning the first, this is how we can shed 
light on the mixed mechanisms of health and disease – we address this further in section 
5.1. Concerning the second, earlier in section 3 we noticed that measurements of the social 
still pertain to the population level. However, with the advent of molecular approaches, 
even epidemiology could reach the individual level. How do these two level relate to each 
other? We address this further in section 5.2. 
5.1 Bio-social mechanisms of disease 
Our proposal is that socio- and bio-markers should be used in combination. In such a way it 
would be possible to finally uncover the mixed, bio-social mechanisms whereby ‘the social’ 
can influence ‘the biological’, returning to a more holistic understanding of the aetiology of 
disease (Kelly et al., 2014; Russo, 2009). 
In the current situation, the biological component of the mechanisms of disease is explored 
at a fine-grained level (explanations of disease at the molecular level are paradigmatic in 
this respect), while the social component is analysed at a rather coarse-grained level, or at 
the level of population using mainly aggregate variables. As a consequence, the mechanisms 
of disease appear to be spelled out only in biological terms, while the study of the social 
components allows researchers only to establish that there are robust correlations between 
specific social factors and some biological outcomes. In line with recent arguments of Kelly 
et al. (2014), and Kelly and Russo (2017) we aim to put the social in the mechanisms 
explaining disease. 
The combination of biomarkers and sociomarkers, we argue, would finally help researchers 
uncover the mixed mechanisms through which ‘the social’ affects health. To begin with, 
17 
 
sociomarkers would fill the gap between biological fine-grained variables, and social coarse-
grained variables, enabling researchers to study both the biological and the social 
components at a fine-grained level. Together, biomarkers and sociomarkers would enable 
researchers to sample the different levels of reality at different time points, and the 
passages from specific sociomarkers to certain biomarkers would provide some compelling 
linkages between these different domains. Given that the continuum traced through these 
markers could involve both social and biological components, it follows that such markers 
would allow for the identification of the key stages of a mixed mechanism of disease, from 
the social components triggering the mechanism, to certain key events involving social or 
biological components, to the biological factors leading to the health outcome. 
Sociomarkers would hence help us recognize, despite their ‘distance from the skin’, the 
epistemic importance of ‘the social’ for the mixed mechanism of disease; and sociomarkers 
and biomarkers together would lead us to reconceptualize, from a mechanistic point of 
view, causality across different types of factors (social and biological). This means that, while 
bio- and sociomarkers are ontologically distinct, a priori they have equal importance in the 
explanation and reconstruction of exposure and disease development. 
5.2 Population and individual causation 
With biomarkers, we study processes that happen at the individual level, and molecular 
epidemiology aims to provide a ‘population-level’ study of them. On the one hand, 
biomarkers are searched for and validated using individual-level data – biosamples pertain 
to individuals; on the other hand, the fact that we can dispose of very large bio-banks or 
cohorts make it possible to make an epidemiological study out of it. So, if we run a study at 
the individual level – and even at a finer grained level (i.e. the molecular level), the ultimate 
goal is to say something at the population level. This, in the early days of molecular 
epidemiology created a tension in the field. As Schulte put it, it might sound an oxymoron to 
do epidemiology with molecular data (Schulte, 1993, p. 10). We agree with Schulte that this 
is not the case, but we are forced to re-think the relation between population- and 
individual-level causal knowledge, and specifically the role of biomarkers in the production 
of generic knowledge of health and disease. Likewise, a large part of social science 
interested in health has worked at the population level, while our proposal to use 
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sociomarkers shifts the level of analysis to the individual level. How do we reconcile these 
different levels of analysis? 
To begin with, it is worth clarifying the terminology used. We endorse the categorisation 
provided by Illari and Russo (2014), and summarised in the table below, taken from their 
work (2014, p. 43). 
 
Table 2: This table, taken from Illari and Russo (2014, p. 43), recaps the terms 
used in the literature, where they apply and their purpose 
Biomarkers are identified using bio-samples of real, particular patients, but their study in 
large data sets allows scientists to make inferences about the population, rather than single 
individuals. The change of the scale of measurement, the size of the sample, and the way in 
which inferences from -omics analyses are made allows us to make something of 
unprecedented novelty: to study individual-level processes in order to understand 
population-level phenomena. 
In analogy to the study of biomarkers, we want to suggest studying sociomarkers. These 
sociomarkers will differ substantially from the widely used social indicators in that they 
allow us to trace social process at the individual level. Again, in analogy with biomarkers, we 
can then develop an ‘epidemiology’ of sociomarkers, and thus gain understanding of the 
social mechanisms that operate at the individual level, but within a group or population. By 
construction, the sought sociomarkers will be those likely to interact with the bio-chemical 
disease mechanisms. With sociomarkers we will be able to trace the onset and development 
of disease in its biological and social aspects. The equal epistemic relevance of bio- and 
socio- markers will help us to reconstruct the mixed mechanism of health, while taking their 
ontological differences into account. Knowledge of the development of sociomarkers, 
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furthermore, can be used for early diagnosis and screening at the individual level, just as it 
happens for biomarkers. 
The introduction of sociomarkers also contributes to avoiding the risk of reductionism in at 
least two senses. Firstly, health and disease are not reduced to the biological realm; instead, 
social factors are active causes in disease aetiology. Secondly, while the study of 
sociomarkers at the individual level help eliciting the mixed mechanisms, health and disease 
are not confined to the individual level; instead, individual-level sociomarkers help 
understand how population-level social risks act.  
6. Conclusion 
The interaction between social and biological components of health has been at the heart of 
several studies in the last few decades. This paper identifies the following challenges, that 
we try to constructively address. First, the increased understanding of the biological factors 
involved in the mixed mechanisms of diseases formation has not been accompanied by an 
appropriate comprehension of the active role played by social factors. It follows that our 
mechanistic understanding is in general obtained only at the biological level, while the social 
level is still studied through correlations between population-level variables. 
Second, concerning the biological components, our mechanistic understanding can be 
achieved at the individual level through the use of biomarkers. In contrast, social 
components are still studied at the population level. 
Third, all these dimensions (individual/population and social/biological) are relevant for the 
purposes of policy interventions. Let us consider obesity: in order to develop an 
intervention, researchers ought to take into account population- and individual-level social 
factors, such as food availability, the presence or absence of walkable neighbourhoods, and 
the individual lifestyle and ideal concerning body size. Similarly, they might consider macro- 
and micro- biological factors, such as the presence of environmental factors and molecular 
mechanisms underlying obesity. 
This paper contributes to addressing these challenges by proposing to use social measures 
as sociomarkers. To describe what sociomarkers are, a parallel with biomarkers has been 
proposed. Both social and biological markers can be understood as ‘intersecting signals’ and 
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can be related in different ways to the causal process under study. Furthermore, in both 
cases markers would help to trace causal processes at the individual level. 
The combination of social and biological markers, in conclusion, would reveal how social 
factors can “get under the skin”, and would help researchers to move from causal claims at 
the population level to causal claims at the individual level.  
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